| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/03/2001 | WO2001000664A3 Secreted alpha-helical protein-36 |
| 05/03/2001 | WO2000078802A3 Secreted polypeptides and corresponding polynucleotides |
| 05/03/2001 | WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 05/03/2001 | WO2000076539A3 A method to improve protective immunity induced by polynucleotide vaccines |
| 05/03/2001 | WO2000076537A3 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases |
| 05/03/2001 | WO2000072876A3 Prevention and treatment of amyloidogenic disease |
| 05/03/2001 | WO2000071165A3 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
| 05/03/2001 | WO2000063245A3 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 05/03/2001 | WO2000056774A8 Methods of using bioelastomers |
| 05/03/2001 | WO2000056298A3 Treatment of lyme disease with polysulfated glycosaminoglycan formulations |
| 05/03/2001 | WO2000039301A3 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants |
| 05/03/2001 | US20010000783 Associated with inhibited epithelial cell proliferation comprising administering a heparin-binding epidermal growth factor-like growth factor (HB-EGF) or derivative, e,g. anantiidiotypic antibody to HB-EGF, gene therapy; angonists |
| 05/03/2001 | DE19951970A1 Arzneimittel für die Toleranzinduktion Medicines for tolerance induction |
| 05/03/2001 | DE19949595A1 CTAGE-Genfamilie CTAGE gene family |
| 05/03/2001 | DE19949179A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid |
| 05/03/2001 | CA2721011A1 Modified gp100 and uses thereof |
| 05/03/2001 | CA2389522A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 05/03/2001 | CA2389321A1 Neisserial antigenic peptides |
| 05/03/2001 | CA2389217A1 Mammalian-type glycosylation in plants |
| 05/03/2001 | CA2389196A1 Cyclic peptides and aids vaccines |
| 05/03/2001 | CA2389110A1 Regulation of gene expression by neuroleptic agents |
| 05/03/2001 | CA2388995A1 Method |
| 05/03/2001 | CA2388974A1 Medicament in order to induce tolerance |
| 05/03/2001 | CA2388950A1 Nucleic acids of the human abc1 gene and their therapeutic and diagnostic application |
| 05/03/2001 | CA2388942A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 05/03/2001 | CA2388642A1 A method and computer system to design primers utilizing a first and second target nucleotide sequence |
| 05/03/2001 | CA2388617A1 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | CA2388337A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 05/03/2001 | CA2388298A1 The use of csf-1 inhibitors |
| 05/03/2001 | CA2387921A1 Invasive bacterial vectors for expressing alphavirus replicons |
| 05/03/2001 | CA2387889A1 Use of a cd40:cd154 binding interruptor to treat immunological complications of the eye |
| 05/03/2001 | CA2387685A1 Stanniocalcin proteins and nucleic acids and methods based thereon |
| 05/03/2001 | CA2387666A1 Redox reversible hcv proteins with native-like conformation |
| 05/03/2001 | CA2387652A1 A method of prophylaxis and treatment |
| 05/03/2001 | CA2387260A1 Non-anaphylactic forms of grass pollen ph1 p 6 allergen and their use |
| 05/03/2001 | CA2386926A1 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/02/2001 | EP1096016A1 Platelet-activating factor acetylhydrolase |
| 05/02/2001 | EP1096009A1 G-protein coupled receptor-like Polypeptide |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095662A1 New vaccine composition and use of surfactants as immuno-adjuvant |
| 05/02/2001 | EP1095417A1 Transition metal based ceramic material and electrodes fabricated therefrom |
| 05/02/2001 | EP1095274A1 Trifunctional reagent for conjugation to a biomolecule |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095143A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 05/02/2001 | EP1095139A2 Secreted proteins |
| 05/02/2001 | EP1095062A1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 05/02/2001 | EP1095060A1 Galectin 11 |
| 05/02/2001 | EP1095059A1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use |
| 05/02/2001 | EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 05/02/2001 | EP1094844A1 Polynucleotide vaccine formulations |
| 05/02/2001 | EP1094837A2 Porcine circovirus and parvovirus vaccine |
| 05/02/2001 | EP1094836A2 Methods of raising animals for meat production |
| 05/02/2001 | EP1094828A1 Use of neglected target tissue antigens in modulation of immune responses |
| 05/02/2001 | CN1293710A Mutant recombinant allergens |
| 05/02/2001 | CN1293568A Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 05/02/2001 | CN1293202A Chimeric toxin including modified targeting part |
| 05/02/2001 | CN1293066A Concatenated antidiotype monoclonic antibody vaccine for fish diseases |
| 05/02/2001 | CN1292993A Concatenated monoclonic antibody medicine for treating fish diseases |
| 05/02/2001 | CN1292992A Medicine kit for concatenated immunodetection of fish diseases |
| 05/02/2001 | CN1065142C Composition used as therapeutic agent against chronic viral hepatic diseases |
| 05/01/2001 | US6225458 Process for the production of DNA comprising the genome of the hepatitis B virus and vector including it |
| 05/01/2001 | US6225449 Hormone analogs with multiple CTP extensions |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225443 Peptide which is associated with immune response; for use in vaccination of humans and diagnostic testing |
| 05/01/2001 | US6225292 Inhibitors of DNA immunostimulatory sequence activity |
| 05/01/2001 | US6225289 Methods and compositions for preserving adenoviral vectors |
| 05/01/2001 | US6225286 Cell surface protein expressed on human cortical thymocyte and their use |
| 05/01/2001 | US6225117 Antibodies against human IL-12 |
| 05/01/2001 | US6225111 Expression vector for the expression of heterologous proteins |
| 05/01/2001 | US6225102 Amino acid sequence of guanosine triphosphatase from streptococcus; diagnosis; prophylaxis; drug screening; bactericides; bacteriostats |
| 05/01/2001 | US6225098 UDP-N-acetylenolpyruvyglucosamine reductase |
| 05/01/2001 | US6225091 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus |
| 05/01/2001 | US6225087 Polynucleotide which codes for a polypeptide of defined amino acid sequence; drug screening of bactericides against streptococcus; otitis media; conjunctivitis; pneumonia; meningitis; sinusitis; pleural empyema; endocarditis |
| 05/01/2001 | US6225085 Nucleotide and amino acid sequence of leucine-rich surface glycoprotein; diagnosis; prophylaxis; therapy; drug screening; fusion proteins; antigenic peptides; antibodies; recombinant production |
| 05/01/2001 | US6225083 Nucleotide and amino acid sequences of membrane protein involved in cell division; drug screening; bactericides; bacteriostats; antibiotics; for meningitis, sinusitis, conjunctivitis, otitis media, and endocarditis |
| 05/01/2001 | US6225054 Compositions and methods for the treatment and diagnosis of breast cancer |
| 05/01/2001 | US6224902 Mixture of delivery vehicle and sterol |
| 05/01/2001 | US6224882 Vaccine containing epitope or antigen |
| 05/01/2001 | US6224881 DNA molecule fragments encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 05/01/2001 | US6224880 Vaccines |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6224878 Culture product; genetic engineering |
| 05/01/2001 | US6224870 Administering a nucleic acid |
| 05/01/2001 | US6224869 Isolated polypeptide |
| 05/01/2001 | US6224868 Reagent and processes for targeting mutant epidermal growth factor receptors |
| 05/01/2001 | US6224866 Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors |
| 05/01/2001 | US6224865 Suppression of inhibitors |
| 05/01/2001 | US6224859 Composition containing immature mammalian dendritic cells for enhancing tolerogenicity to foreign graft |
| 05/01/2001 | CA2286301A1 The filamentous phage as a multivalent scaffold for coupling synthetic peptides for immunization |
| 05/01/2001 | CA2253078C Immunological composition and its method of use to transiently disrupt mammalian central nervous system myelin to promote neuronal regeneration |
| 05/01/2001 | CA2140624C P53 vaccine |
| 05/01/2001 | CA2081660C Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method |
| 05/01/2001 | CA2067333C Production of genetically-engineered vaccines for aids and retroviral diseases |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029226A2 Apoptosis inducing proteinaceous substance |
| 04/26/2001 | WO2001029220A2 Mage-a12 antigenic peptides and uses thereof |
| 04/26/2001 | WO2001029217A2 Novel polypeptides and polynucleotides encoding same |